Company intelligence / Profile preview

Saisei Ventures

Cambridge, Massachusetts, United Statessaiseiventures.com ↗

Ownership: Private
Development stage: Other

Overview

Saisei Ventures invests in early-stage biotech companies with innovative approaches in regenerative medicine and advanced therapeutics. Their portfolio includes ventures advancing toward clinical proof-of-concept and IND filings, with a focus on scalable manufacturing and global market potential. They do not directly conduct clinical trials themselves.

Therapeutic areas: Rare Diseases
Modalities: Cell therapy (including cell immunotherapies)Gene therapy (in vivo and ex vivo approaches)Pluripotent cell replacement therapiesAdvanced therapeutic platforms (general category)
Industry: Investors

Partnerships

Japanese academic institutionsInternational investorsEntrepreneursScientists

Beyond the preview

Go deeper on Saisei Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Saisei Ventures.

Explore the full profile